Skip to content
ANDREESSEN HOROWITZ
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • Bio
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Fintech
    • Gaming & Social
    • Security & Privacy
    • Marketplaces
    • Enterprise & SaaS
    • Bio
    • Consumer
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
Close

Andy Tran

Andy Tran Follow LinkedIn

Andy is a partner on the bio investment team, where he focuses on companies at the intersection of biology, engineering, and healthcare.

Prior to joining a16z, Andy worked in Genentech’s Discovery Oncology department, where he developed high-throughput, genome-wide screens and computational tools for identifying novel cancer targets. Before that, Andy worked with Professor George Church at the Harvard Medical School/Wyss Institute, where he engineered CRISPR genome editing technologies for therapeutic applications. Andy also analyzed high-growth technology companies in the investment banking division of Morgan Stanley.

Andy studied Bioengineering and Computer Science at Harvard University, where he focused on genomics and machine learning. He was awarded the First Place Grand Award in Medicine at the Intel International Science and Engineering Fair.

While not searching for the next frontier in bio, Andy enjoys playing the guitar, building computers, and swimming.

Latest Posts

Evaluating AI in Bio: How to Know Whether it is Worth the Work

by Andy Tran and Vijay Pande
  • AI, machine & deep learning
  • bio
  • AI in bio

Platform-Disease Fit: Why You Need It and How to Find It

by Andy Tran and Jorge Conde
  • bio
  • building a bio company
  • Company Building 101
  • therapeutics

Journal Club: Turning a Toxin into a Genome Editing Tool

by Jorge Conde, Andy Tran, and Lauren Richardson
  • bio
  • a16z Journal Club
  • gene editing including CRISPR
  • when science becomes engineering

Upgrading cell and gene therapy “software” for safety; Pharma picks their PROTAC horses; The first healthtech giant; and more

by a16z editorial, Andy Tran, and Judy Savitskaya
  • bio
  • coronavirus & the COVID-19 pandemic
  • digital health
  • gene editing including CRISPR
  • healthcare
  • pharma
  • therapeutics
  • when science becomes engineering

From @andy23tran

Susanna L Harris@SusannaLHarris

If we pay undergrads $15 per hour, what next? Pay our grad students a living wage?? Give our post docs health care??? Treat associate professors like people???? Slippery slope.

Jorge Conde@JorgeCondeBio

The mRNA vaccine for COVID19 was designed in silico in 48hrs; updated versions against mutant strains can be rapidly produced. Computer ‘virus’ was named after its biological counterpart; update-able mRNA ‘antivirus’ looks like its software counterpart. VaaS! (h/t @davidu)

Joe Biden@JoeBiden

Science will always be at the forefront of my administration — and these world-renowned scientists will ensure everything we do is grounded in science, facts, and the truth. https://t.co/fEbgDMkTDZ

Software is eating the world
© 2021 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are